Hidden Hypertension: Can Health Surveys Close Detection

Why can routine health records miss undiagnosed hypertension?

The World Health Organization's SCORE technical package connects population surveys, routine records and other information sources to improve health decisions. Its original announcement was published on August 27, 2020; this is an examination of that established framework, rather than a newly announced launch. One particularly consequential application is identifying conditions that can remain silent for years. A clinic database can describe diagnosed patients accurately while revealing little about people who have never had their blood pressure checked. [WHO's SCORE announcement](https://www.who.int/news/item/27-08-2020-new-who-technical-package-health-data-for-covid-19-response).

WHO estimates that 1.4 billion adults aged 30–79 had hypertension in 2024. Approximately 44% were unaware of it, while only 23% had it controlled. These are population estimates, not a count of clinic registrations. Because high blood pressure often produces no symptoms, waiting for people to feel unwell leaves opportunities for prevention unused. Untreated hypertension can damage the heart, brain and kidneys. The surveillance implication is clear: recorded diagnoses alone cannot establish how much disease remains undetected. [WHO hypertension fact sheet](https://www.who.int/en/news-room/fact-sheets/detail/hypertension).

How do population surveys reveal hidden high blood pressure?

WHO's STEPwise approach to noncommunicable disease risk factor surveillance, known as STEPS, uses standardized questionnaires and physical measurements to assess risks including raised blood pressure. Measuring participants matters because asking whether someone has hypertension will miss people who do not know. Consistent methods also make repeated surveys more informative: an apparent change is easier to interpret when the questions and measurement procedures remain comparable. Surveys complement clinical records by examining health across a sampled population, including people outside regular care. [WHO STEPS framework](https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps).

However, a survey result and an individual diagnosis serve different purposes. An elevated screening measurement needs appropriate clinical assessment. The US Preventive Services Task Force recommends screening adults without known hypertension and confirming a diagnosis with measurements outside the clinical setting before starting treatment. Options include home monitoring or an ambulatory device that records blood pressure during everyday activities. This confirmation helps distinguish persistently elevated pressure from a temporary rise during a healthcare visit. A survey can reveal a population problem while participants still need follow-up to establish their own diagnosis. [USPSTF screening recommendation](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening).

How can better hypertension data lead to better care?

Finding more people with elevated blood pressure is only the beginning. WHO's 2025 hypertension report identifies barriers including limited access to validated measuring devices, insufficiently trained care teams, costly medicines and unreliable medicine supplies. These obstacles explain why a screening campaign alone cannot guarantee better outcomes. Effective programs need a route from an abnormal measurement to assessment, affordable treatment and continuing follow-up. Monitoring whether blood pressure becomes controlled provides more meaningful information than reporting only how many checks were performed. [WHO hypertension report announcement](https://www.who.int/news/item/23-09-2025-uncontrolled-high-blood-pressure-puts-over-a-billion-people-at-risk).

A practical implication is to examine each stage separately. A large undiagnosed population suggests a detection gap; many diagnosed but untreated people suggest barriers after diagnosis; persistent high readings among treated patients indicate a need to examine ongoing care. Those patterns guide investigation but do not establish the cause of a gap by themselves. For example, a treatment record cannot prove that someone could obtain every prescription. SCORE's emphasis on using information for decisions supports this approach: collecting data matters when it leads to a specific service improvement whose results can then be measured. [WHO's SCORE framework](https://www.who.int/news/item/27-08-2020-new-who-technical-package-health-data-for-covid-19-response).